Advertisement

Topics

Biolipox AB (publ.) Company Profile

11:14 EDT 22nd September 2017 | BioPortfolio

Biolipox is a research-intensive pharmaceutical companyThe core of Biolipox's operations is world-leading research on arachidonic acid and its effects on inflammatory diseases - particularly asthma, chronic obstructive pulmonary disease (COPD), rhinitis, pain and arthritis. The discoveries that form the basis of our understanding of the role of arachidonic acid in inflammatory processes were rewarded with the Nobel Prize in 1982. One of the prize winners, Professor Bengt Samuelsson, is currently a member of the Board of Biolipox.

Arachidonic acid is an endogenous substance that through transformation to prostaglandins and leukotrienes regulates a number of inflammatory processes in the body. Biolipox's discovery of a new family - eoxins - formed from the transformation of arachidonic acid, marked the beginning of the company's research on an entirely new class of anti-inflammatory drugs

Location

Berzelius väg 3, plan 5
Solna
Sweden

Contact

Phone: 46 8-524 83 100
Fax: 46 8 524 83 101
Email: info@biolipox.com


News Articles [38 Associated News Articles listed on BioPortfolio]

Oasmia Pharmaceutical AB: Change in the number of shares and votes in Oasmia Pharmaceutical AB (publ)

Uppsala, Sweden, 2017-07-31 22:05 CEST (GLOBE NEWSWIRE) -- Oasmia Pharmaceutical AB (publ) ("Oasmia" or "Company" or "Group") has, as has been previously announced, carried out a rights issue. Appr...

Skandinaviska Enskilda Banken AB publ Has $15.54 Million Position in...

Skandinaviska Enskilda Banken AB publ raised its position in shares of Bristol-Myers Squibb Company by 0.0% during the first quarter, according to its most recent Form 13F filing with the Securities a...

Oasmia Pharmaceutical AB: Oasmia Pharmaceutical AB (publ) replaces current convertible loan with new debt

The board of directors in Oasmia Pharmaceutical AB (publ) ("Oasmia" or the "Company") announces that it has agreed with the holders of convertibles in Oasmia's convertible loan programme 2016:2 to ...

Oasmia Pharmaceutical AB: Oasmia Pharmaceutical AB (publ): The board of directors resolves upon a rights issue of approximately 163.9 MSEK

The board of directors of Oasmia Pharmaceutical AB (publ) ("Oasmia" or the "Company") announces that the board of directors on 11 June 2017 has resolved to, based on an authorisation from the annua...

Oasmia Pharmaceutical AB: Issuance of warrants in Oasmia Pharmaceutical AB (publ)

Oasmia Pharmaceutical AB (publ) (the "Company") resolved, at the Extraordinary General Meeting of the Company on 2 June 2017, to establish two warrant programmes, series 2017:1 and series 2017:2, i...

Oasmia Pharmaceutical AB: Oasmia Pharmaceutical AB (publ) announces result of the rights issue

Uppsala, Sweden, 2017-07-07 22:05 CEST (GLOBE NEWSWIRE) -- The subscription period for Oasmia Pharmaceutical AB's (publ) ("Oasmia" or the "Company") rights issue ended on July 5, 2017. The result o...

Oasmia Pharmaceutical AB: Oasmia Pharmaceutical AB (publ) publishes prospectus by reason of the Rights Issue

The board of directors of Oasmia Pharmaceutical AB (publ) ("Oasmia", "Company" or "Group") has prepared a prospectus ("Prospectus") concerning the new issue of shares with preferential rights for t...

CellaVision AB: Bulletin from the Annual General Meeting of CellaVision AB (publ) held on May 5, 2017

CellaVision AB (publ) held its Annual General Meeting today, 5 May 2017, in Lund. The meeting resolved upon the following: Payment of dividend in the amount of SEK 1,50 per share with 9 May 2017 a...

Drugs and Medications [2 Associated Drugs and Medications listed on BioPortfolio]

Kepivance [Swedish Orphan Biovitrum AB (publ)]

These highlights do not include all the information needed to use Kepivance safely and effectively. See full prescribing information for Kepivance.Kepivance® (palifermin) For injection, for intraveno...

Kineret [Swedish Orphan Biovitrum AB (publ)]

These highlights do not include all the information needed to use Kineret safely and effectively. See full prescribing information for Kineret. Kineret® (anakinra) For injection, for subcutaneous use...

PubMed Articles [0 Results]

None

Clinical Trials [0 Results]

None

Companies [16 Associated Companies listed on BioPortfolio]

Biolipox AB (publ.)

Biolipox is a research-intensive pharmaceutical companyThe core of Biolipox's operations is world-leading research on arachidonic acid and its effects on inflammatory diseases - particularly asthma, c...

Biolipox AB

Biolipox is a research-intensive pharmaceutical companyThe core of Biolipox's operations is world-leading research on arachidonic acid and its effects on inflammatory diseases - particularly asthma, c...

Swedish Orphan Biovitrum AB (publ)

Karolinska Development AB (publ), and BioChromix AB

Karolinska Development manages one of the largest portfolios of life science companies in Europe.

Vitrolife AB (publ)

The fourth of the total of twelve patients included in the USA study for STEEN Solution™, and which enables sales approval in the important USA market, has now received a tra...

More Information about "Biolipox AB (publ.)" on BioPortfolio

We have published hundreds of Biolipox AB (publ.) news stories on BioPortfolio along with dozens of Biolipox AB (publ.) Clinical Trials and PubMed Articles about Biolipox AB (publ.) for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Biolipox AB (publ.) Companies in our database. You can also find out about relevant Biolipox AB (publ.) Drugs and Medications on this site too.

Quick Search
Advertisement
 

Relevant Topics

Allergies
The term allergy is used to describe a response, within the body, to a substance, which is not necessarily harmful in itself, but results in an immune response and a reaction that causes symptoms and disease in a predisposed person, which in turn can cau...

COPD (chronic obstructive pulmonary disease)
COPD (chronic obstructive pulmonary disease) is used for a number of conditions including chronic bronchitis and emphysema, which all  lead to the airways in the lungs becoming damaged and thus narrower,  making inhalation and exhalation harder...

Pulmonary
Pulmonary relating to or associated with the lungs eg Asthma, chronic bronchitis, emphysema, COPD, Cystic Fibrosis, Influenza,  Lung Cancer, Pneumonia, Pulmonary Arterial Hypertension, Sleep Disorders etc Follow and track Lung Cancer News ...


Corporate Database Quicklinks



Searches Linking to this Company Record